BioSpace News Archive

The meeting, which brings together over 30,000 researchers from more than 80 countries, is taking place from November 11-15 in Washington, DC.

Genisphere completed the raise to support accelerating interest in advancing its 3DNA scaffold into the clinic and enabling follow-on studies and programs currently underway with biotech and pharma partners.

[01-November-2017] AUSTIN, Texas, Nov. 1, 2017 /PRNewswire/ -- ASPiRA Labs, a Vermillion company (NASDAQ: VRML) and the exclusive distributor of OVA1 (Multivariate Index Assay) (MIA), today announced that it has substantially expanded positive policy coverage with the addition of 14 key managed care providers. This positive coverage is a transition from negative policy to positive policy f

The Company will host a conference call and webcast to discuss its financial and business results on the same day at 4:30 p.m. ET.

Cytel announced that it has partnered with New Mountain Capital, a growth-oriented investment firm that currently manages over $20 billion in assets.

The program furthers Vertex’s commitment to the next generation of CF researchers by expanding the existing CF Research Innovation Awards program.

Singulex today announced it has filed a 510(k) pre-market notification submission with the FDA for its Singulex Clarity cTnI assay to run on the Singulex Clarity system.

The makers of hydraSense are pleased to introduce the hydraSense daily nasal care line to the U.S. market.

FDA has agreed to the proposed CMC, preclinical, and clinical development plans for NT219.

Syros today announced that initial clinical data from the ongoing Phase 2 trial of SY-142 will be presented at the ASH Annual Meeting and Exposition taking place December 9-12 in Atlanta.